Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Movement disorders: classifications.

C Klein1

  • 1Department of Neurology, University of Lübeck, Lübeck, Germany. klein_ch@neuro.mu-luebeck.de

Journal of Inherited Metabolic Disease
|May 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Premotor Gray Matter Volume is Associated with Clinical Findings in Idiopathic and Genetically Determined Parkinson's Disease.

The open neuroimaging journal·2009
Same author

Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

Experimental neurology·2009
Same author

Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles.

Journal of neurology, neurosurgery, and psychiatry·2009
Same author

Imaging the impact of genes on Parkinson's disease.

Neuroscience·2009
Same author

The D216H variant in the DYT1 gene: a susceptibility factor for dystonia in familial cases?

Neurology·2009
Same author

Somatosensory processing in a German family with PINK1 mutations: its potential role in Parkinson disease.

Journal of neurology, neurosurgery, and psychiatry·2009
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

Classifying heterogeneous movement disorders is challenging due to complex genetics and lack of diagnostic tests. Current schemes integrate clinical, pathological, and genetic data, but refinement is ongoing.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Movement disorders exhibit significant clinical, pathological, and genetic heterogeneity.
  • Existing classification systems for movement disorders have limitations, including diagnostic test scarcity and complex categorizations.
  • Historical advancements, particularly in molecular neurogenetics, have influenced current classification approaches.

Purpose of the Study:

  • To review the complexities and evolution of movement disorder classification systems.
  • To highlight the integration of clinical, pathological, and genetic criteria in modern classifications.
  • To emphasize the ongoing need for research to refine movement disorder categorizations.

Main Methods:

  • Review of historical and modern classification schemes for movement disorders.

Related Experiment Videos

  • Analysis of clinical, pathological, and genetic/molecular criteria used in categorization.
  • Examination of the impact of molecular neurogenetics on classification.

    • Main Results:

    • Classification schemes have evolved, integrating multiple criteria but still face challenges.
    • Clinical classification based on symptoms and disease course remains highly practical.
    • Genetic and molecular data are increasingly vital for precise classification, with examples like trinucleotide expansions.

    Conclusions:

    • No single 'ultimate' classification exists for movement disorders due to their complexity.
    • Integrated approaches combining clinical, pathological, and genetic data are essential.
    • Continued collaborative research is necessary to refine and redefine movement disorder classifications.